Posted in | News | Pollution | Recycling

New Nature Publication Confirms CARBIOS’ Leadership in Enzymatic Degradation of Plastic

CARBIOS, a pioneer in the development and industrialization of biological technologies to reinvent the life cycle of plastic and textiles, announces the publication of a new article entitled “An engineered enzyme embedded into PLA to make self-biodegradable plastic” in Nature, widely regarded as the most influential scientific journal, and co-authored with its longstanding collaborator, the Toulouse Biotechnology Institute (TBI). 

Figure 1: CARBIOS publishes a new article entitled “An engineered enzyme embedded into PLA to make self-biodegradable plastic” in Nature. Image Credit: CARBIOS

Enzyme-embedded PLA plastic can fully and rapidly degrade in home-compost or methanization conditions.  The article describes the optimization process used to achieve an engineered enzyme able to withstand the 170 °C temperature required to introduce it in molten state PLA during the plastic production process. 

The new enzyme-embedded material is proven to fully distintegrate and biodegrade at a much faster rate than the 26-week home-compost certification requirement and is also shown to help produce more biomethane, another source of waste recovery.  Moreover, the material remains intact over long-term storage, the enzyme only being activated under composting or methanization conditions, ensuring compatibility with commercial PLA-based applications, for example, flexible packaging (such as sauce packets and wrappers) and short-life items (such as food containers, yogurt pots and coffee capsules).

CARBIOS Active: CARBIOS’ commercial biodegradation solution is the direct result of the unique know-how developed by its enzymology experts

CARBIOS’ expertise in enzyme optimization contributed to the development of CARBIOS Active’s formula and industrial process. Integrated directly into the plastic material transformation process without any modification to production lines, the encapsulated enzyme CARBIOS Active enables the creation of a new generation of PLA products that are 100% compostable at ambient temperature, while ensuring quality compost, free from toxicity and microplastics.

CARBIOS Active therefore opens up new biodegradation possibilites for PLA at ambient temperatures, including domestic composting conditions. A production line is already up and running at CARBIOS headquarters in Clermont-Ferrand, France, which can produce 2,500 tons/year of CARBIOS Active (required for the equivalent of 50,000 tons/year of enzyme-embedded PLA).

Alain MARTY, Chief Scientific Officer, CARBIOS: "A publication in Nature is an especially proud moment for all the contributing teams, notably recognition from peers in the scientific community.  Developing an efficient enzyme that can withstand the 170 °C needed to introduce it into PLA is an outstanding scientific feat! Our previous article published in Nature in 2020 was pivotal in bringing our PET biorecycling technology to the world stage. 

We are very excited by the enhanced visibility of CARBIOS’ unique biodegradation technology brought by this publication, as it offers a practical and scalable approach to various industrial PLA-based packaging applications."

Emmanuel Ladent, CEO, CARBIOS: “CARBIOS Active is the real-life application of CARBIOS’ expertise in enzyme optimization and polymer science.  As CARBIOS expands its portfolio of enzymatic solutions beyond PET, enzyme-embedded PLA represents a major leap forward, addressing a critical gap in the market for compostable plastic. The recognition from the scientific community through this new publication in Nature comes in addition to recent certifications, such as the Food Contact Notification delivered by the FDA in North America, to attest CARBIOS Active’s performance and support its commercial deployment.  Thanks to our long-term and exclusive partnership with Novonesis, we are transforming this scientific breakthrough into reality.”

Isabelle André, Research Director at CNRS: "I am immensely proud that the efforts and dedication of the researchers at TBI and our long-term partners at CARBIOS have been recognized by the journal Nature. This pioneering work on enzyme-embedded PLA to make self-biodegradable plastic is testament to our commitment to developing sustainable solutions with enzyme engineering at the core.”

The article is co-authored by biotechnology researchers from CARBIOS and its academic partner Toulouse Biotechnology Institute (TBI), as well as two eminent professors from University of Mons (Belgium) and Kasetsart University of Bangkok (Thailand). Once again, this collaboration demonstrates CARBIOS' ambition and ability to rally partners together in an efficient ecosystem to bring a collective solution to a major environmental challenge.

Source:

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    CARBIOS. (2024, July 18). New Nature Publication Confirms CARBIOS’ Leadership in Enzymatic Degradation of Plastic. AZoCleantech. Retrieved on September 07, 2024 from https://www.azocleantech.com/news.aspx?newsID=35013.

  • MLA

    CARBIOS. "New Nature Publication Confirms CARBIOS’ Leadership in Enzymatic Degradation of Plastic". AZoCleantech. 07 September 2024. <https://www.azocleantech.com/news.aspx?newsID=35013>.

  • Chicago

    CARBIOS. "New Nature Publication Confirms CARBIOS’ Leadership in Enzymatic Degradation of Plastic". AZoCleantech. https://www.azocleantech.com/news.aspx?newsID=35013. (accessed September 07, 2024).

  • Harvard

    CARBIOS. 2024. New Nature Publication Confirms CARBIOS’ Leadership in Enzymatic Degradation of Plastic. AZoCleantech, viewed 07 September 2024, https://www.azocleantech.com/news.aspx?newsID=35013.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.